Global Hyperphosphatemia Drugs Market to Grow 12.5% to 2015 Says New Report
The report ‘Global Hyperphosphatemia Drugs Market 2011-2015’ states that the Hyperphosphatemia drugs market will grow 12.5% to 2015. One of the major factors driving this market growth is the increasing prevalence of chronic kidney disease. The Hyperphosphatemia drugs market has also been witnessing the trend of an growing number of strategic alliances among vendors. However, side effects caused by the hyperphosphatemia drugs could pose a challenge to the growth of this market. The